New Drug
Options
prezmic
Member Posts: 36
0
Comments
-
Thanks for posting
Enzalutamide is the name for the MDV 3100 drug which just finished trials for the treatment of prostate cancer and that belongs to the so called second-line hormonal therapy. This is a newer drug that better address intratumoral activity of cancer cells as a inhibitor of the androgen recptor. Other drugs in the same group but acting in different pathways are abiraterone (Zytiga), orteronel (TAK-700), galeterone (TOK-001), voriconazole (VFEND), cabozantinib (XL184) and APC-100.
You may check for details typing its name in the net.
The typical treatment with antiandrogens such as bicalutamide (Casodex) is limited and does not address intratumoral activity of cancerous cells that start producing its own androgens to survive. The new AR inhibitors are more “refined” in targeting the cancer cell. In other words, refractory to drugs like Casodex could be expected to occur from the initial stage of the treatment because intratumoral activity was not being addressed. The intratumoral “manufacturing” of androgens in the cells could already exist at the time a patient starts the treatment. In future these drugs will substitute the typical “arsenal” drugs of HT.
Improvement of symptoms are expected but not avoided totally. Constant checkups of lipids are advisable.
Best.
VG0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.2K Cancer specific
- 2.8K Anal Cancer
- 440 Bladder Cancer
- 306 Bone Cancers
- 1.6K Brain Cancer
- 28.4K Breast Cancer
- 391 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 12.9K Head and Neck Cancer
- 6.3K Kidney Cancer
- 666 Leukemia
- 789 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 235 Multiple Myeloma
- 7.1K Ovarian Cancer
- 53 Pancreatic Cancer
- 486 Peritoneal Cancer
- 5.3K Prostate Cancer
- 1.2K Rare and Other Cancers
- 532 Sarcoma
- 717 Skin Cancer
- 647 Stomach Cancer
- 190 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards